[go: up one dir, main page]

DK0533739T3 - Injicerbart farmaceutisk præparat - Google Patents

Injicerbart farmaceutisk præparat

Info

Publication number
DK0533739T3
DK0533739T3 DK91910762.3T DK91910762T DK0533739T3 DK 0533739 T3 DK0533739 T3 DK 0533739T3 DK 91910762 T DK91910762 T DK 91910762T DK 0533739 T3 DK0533739 T3 DK 0533739T3
Authority
DK
Denmark
Prior art keywords
microspheres
formulations
contain
dia
microns
Prior art date
Application number
DK91910762.3T
Other languages
Danish (da)
English (en)
Inventor
Garza Flores Josue
Soto Laura P Laiseca
Pichardo Jose Guillen
Uribe Juan Angeles
Original Assignee
Aplicaciones Farmaceuticas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Farmaceuticas filed Critical Aplicaciones Farmaceuticas
Application granted granted Critical
Publication of DK0533739T3 publication Critical patent/DK0533739T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91910762.3T 1990-06-14 1991-06-12 Injicerbart farmaceutisk præparat DK0533739T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9007416A FR2663223B1 (fr) 1990-06-14 1990-06-14 Forme galenique parenterale.

Publications (1)

Publication Number Publication Date
DK0533739T3 true DK0533739T3 (da) 1995-01-09

Family

ID=9397598

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91910762.3T DK0533739T3 (da) 1990-06-14 1991-06-12 Injicerbart farmaceutisk præparat

Country Status (30)

Country Link
US (3) US5360616A (fi)
EP (1) EP0533739B1 (fi)
JP (1) JP2675675B2 (fi)
KR (1) KR0157439B1 (fi)
CN (1) CN1057442C (fi)
AT (1) ATE109658T1 (fi)
AU (1) AU661275B2 (fi)
BG (1) BG61179B1 (fi)
BR (1) BR9106545A (fi)
CA (1) CA2085344C (fi)
CZ (1) CZ286793B6 (fi)
DE (1) DE69103419T2 (fi)
DK (1) DK0533739T3 (fi)
ES (1) ES2059142T3 (fi)
FI (1) FI107698B (fi)
FR (1) FR2663223B1 (fi)
HU (1) HUT68709A (fi)
IE (1) IE62679B1 (fi)
IL (1) IL98459A (fi)
NO (1) NO302998B1 (fi)
NZ (1) NZ238542A (fi)
PL (1) PL167234B1 (fi)
PT (1) PT97975B (fi)
RU (1) RU2104692C1 (fi)
SK (1) SK280564B6 (fi)
TN (1) TNSN91048A1 (fi)
UA (1) UA27043C2 (fi)
UY (1) UY23240A1 (fi)
WO (1) WO1991019484A1 (fi)
ZA (1) ZA914550B (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FR2732621B1 (fr) * 1995-04-10 1997-06-06 Rhone Poulenc Chimie Perles d'un produit presentant le phenomene de surfusion et leur procede d'obtention
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
CA2321924A1 (en) * 1998-02-25 1999-09-02 Abbott Laboratories Butorphanol sustained release formulations
AU6852900A (en) * 1999-08-20 2001-03-19 Norton Healthcare Ltd Method to produce powders for pulmonary or nasal administration
US20070254009A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic/bone morphogenic protein formulation and method of treatment
US20030055075A1 (en) * 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
US20070254008A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic formulation and method of treatment
GB0117696D0 (en) * 2001-07-20 2001-09-12 Bradford Particle Design Plc Particle information
EP1844765B1 (en) * 2003-06-13 2015-01-21 Skendi Finance, Ltd. Slow release estradiol-progesterone formulation
US20050032811A1 (en) 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
AU2004267956B2 (en) 2003-09-03 2010-09-16 Miscon Trading S.A. Methods for the treatment of endometriosis
PT1684782E (pt) 2003-10-03 2015-12-21 Thorn Bioscience Llc Processo para a sincronização da ovulação para reprodução regulada sem detecção do cio
PT1675573E (pt) 2003-10-23 2008-12-30 Otsuka Pharma Co Ltd Formulação de iripiprazole injectável estéril de libertação controlada e um processo para a sua preparação
US7413690B1 (en) 2003-10-29 2008-08-19 The University Of Mississippi Process and apparatus for producing spherical pellets using molten solid matrices
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US7392635B2 (en) * 2005-06-09 2008-07-01 Tipper Tie, Inc. Breech loader packaging systems and associated breech loading chutes and methods
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
JP5419699B2 (ja) 2006-10-31 2014-02-19 エボニック コーポレイション 球状化されたポリマー粒子
JP4879349B2 (ja) 2007-07-31 2012-02-22 大塚製薬株式会社 アリピプラゾール懸濁液及び凍結乾燥製剤の製造方法
US20110104289A1 (en) * 2008-04-14 2011-05-05 Posi Visionary Solutions Llp Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
PL2421545T3 (pl) 2009-04-23 2018-05-30 Jbs United Animal Health Ii Llc Sposób i kompozycja do synchronizacji czasu inseminacji
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
JP2016508030A (ja) 2012-11-28 2016-03-17 ジェイビーエス ユナイテッド アニマル ヘルス セカンド エルエルシー 未経産ブタにおける授精の時期を同期化するための方法および組成物
WO2017105512A1 (en) 2015-12-18 2017-06-22 Proinvet Innovations S.A. Formulations and methods for controlling the reproductive cycle and ovulation
US12290523B2 (en) 2016-02-24 2025-05-06 Eastern Virginia Medical School Formulation of long-acting levonorgestrel butanoate injectable depot suspension
CN106063783B (zh) * 2016-06-16 2019-03-12 浙江爱生药业有限公司 一种黄体酮缓释微囊制剂及其制备方法
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
CN115212170B (zh) * 2021-04-19 2024-01-26 中国人民解放军军事科学院军事医学研究院 一种致密圆整的药物球形微晶及其制备方法和其应用
CN116036022A (zh) * 2021-12-24 2023-05-02 中国人民解放军军事科学院军事医学研究院 一种新型的含载体材料的药物微球制备及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670438A (fi) * 1964-10-06 1966-01-31
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3928566A (en) * 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
JPS5017525A (fi) * 1973-06-14 1975-02-24
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
US4349580A (en) * 1978-08-18 1982-09-14 Queen's University At Kingston Process and solution for preserving green plant tissues
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
IL79407A (en) * 1985-08-01 1991-03-10 Theragenics Corp System and method for delivering insoluble material into a living body
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.
US4892734A (en) * 1987-04-06 1990-01-09 Endocon, Inc. Dispensing paste for forming medicinal pellets
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
WO1988007816A1 (en) * 1987-04-06 1988-10-20 Endocon, Inc. Flash flow fused medicinal implants
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
CA2030551C (en) * 1989-05-01 1998-08-25 Wayne Gombotz Process for producing small particles of biologically active molecules

Also Published As

Publication number Publication date
CA2085344C (en) 1998-06-30
FR2663223A1 (fr) 1991-12-20
EP0533739B1 (fr) 1994-08-10
DE69103419D1 (de) 1994-09-15
KR0157439B1 (ko) 1998-11-16
PT97975A (pt) 1992-04-30
CS181691A3 (en) 1992-06-17
IE912017A1 (en) 1991-12-18
PT97975B (pt) 1998-11-30
UY23240A1 (es) 1991-07-12
CZ286793B6 (cs) 2000-07-12
ATE109658T1 (de) 1994-08-15
ES2059142T3 (es) 1994-11-01
FI925661L (fi) 1992-12-11
ZA914550B (en) 1992-03-25
NO924792D0 (no) 1992-12-11
NO924792L (no) 1993-02-03
AU8084791A (en) 1992-01-07
EP0533739A1 (fr) 1993-03-31
IL98459A (en) 1996-09-12
IL98459A0 (en) 1992-07-15
FI107698B (fi) 2001-09-28
CN1057961A (zh) 1992-01-22
BG61179B1 (bg) 1997-02-28
SK280564B6 (sk) 2000-03-13
IE62679B1 (en) 1995-02-22
BG97166A (bg) 1993-12-24
CA2085344A1 (en) 1991-12-15
RU2104692C1 (ru) 1998-02-20
PL167234B1 (pl) 1995-08-31
WO1991019484A1 (fr) 1991-12-26
NO302998B1 (no) 1998-05-18
FR2663223B1 (fr) 1994-12-02
AU661275B2 (en) 1995-07-20
HU9203958D0 (en) 1993-03-29
TNSN91048A1 (fr) 1992-10-25
US5633014A (en) 1997-05-27
NZ238542A (en) 1993-09-27
PL290677A1 (en) 1992-11-30
UA27043C2 (uk) 2000-02-28
US5512303A (en) 1996-04-30
JPH05507694A (ja) 1993-11-04
HUT68709A (en) 1995-07-28
CN1057442C (zh) 2000-10-18
JP2675675B2 (ja) 1997-11-12
DE69103419T2 (de) 1995-03-30
FI925661A0 (fi) 1992-12-11
BR9106545A (pt) 1993-06-01
US5360616A (en) 1994-11-01

Similar Documents

Publication Publication Date Title
DK0533739T3 (da) Injicerbart farmaceutisk præparat
IL170181A (en) (4r) and (4s)-diastereoisomers of (2s)-2-[oxy-4-propylpyrrolidinyl]butanamide, pharmaceutical compositions comprising them and their use for preparing medicaments
ATE77946T1 (de) Injizierbares langwirkendes mikroteilchenpr|parat zur verabreichung entzuendungshemmender mittel.
HRP20040033B8 (hr) Sustav inhaliranja suhog praška za transpulmonarno davanje
AU7479796A (en) Preparation of peptide containing biodegradable microspheres by melt process
BR9808331A (pt) Aparelho para quebra de partìculas e separação das partìculas de produto e partìculas residuais e composição de partìculas
ZA845208B (en) Solid pharmaceutical formulations for slow,zero order release via controlled surface erosion:expanded range
GEP20032868B (en) Triazolo-Pyridazine Derivatives as Ligands for Gaba Receptors, Methods for Their Production, Pharmaceutical Compositions Containing the Same for Treatment and/or Prevention of disorders of Central Nervous System
DZ2303A1 (fr) Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
BR9809279A (pt) Procedimento para produção de uma fração de blocos g e/ou blocos m a partir de alginato
CA2523883A1 (en) Antisolvent solidification process
CA2032068A1 (en) Pharmaceutical lozenges
CA2339934A1 (en) Medicine for multiple sclerosis
FI951357L (fi) Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen
IL113178A0 (en) 8 alpha-3-hydroxyestra-1,3,5(11) tetraen-17-one (delta9(11)-dehydro-8 isoestrone its preparation andpharmaceutical composition containing it and its use
JP2001524513A5 (fi)
DK0482183T3 (da) Histamin-H3-receptoragonistforbindelser til terapeutisk anvendelse, farmaceutiske sammensætninger virkende som agonister for nævnte receptor og fremstillingsmetode
MA26437A1 (fr) Derives de trans-piperazine-1-yl-spiro (cyclohexane-1,1'-isobenzofuranne), procede pour leur preparation et compositions pharmaceutiques les contenant.
AU8337391A (en) Microcapsules having a combined atelocollagen/polyholoside wall coagulated by a divalent cation
FR2656606B1 (fr) Utilisation de derives du 9,10-dihydrophenanthrene pour la preparation d'un medicament anti-tumoral, application a titre de medicaments de derives du 9,10-dihydrophenanthrene et produits derives de cette structure.
BE901254A (fr) Formulations pharmaceutiques et veterinaires.
CA2250115A1 (en) Fast disintegrating oral dosage form
BR9611407A (pt) Derivados de 1-arilsulfonila, aril(tio)carbonil-piridazino e métodos de preparação.